Skip to main content
IP Group PLC logo

IP Group PLC — Investor Relations & Filings

Ticker · IPO ISIN · GB00B128J450 LEI · 213800HG22UM138WFG43 IL Financial and insurance activities
Filings indexed 1,205 across all filing types
Latest filing 2025-01-09 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL IPO

About IP Group PLC

https://www.ipgroupplc.com/

IP Group PLC is an intellectual property commercialization firm that specializes in creating, building, and supporting early-stage, science-based businesses. The company provides capital, expertise, and strategic guidance to innovators, helping to transform groundbreaking research into tangible impact. Its investment portfolio is focused on three core sectors: life sciences, aimed at curing and preventing disease; deeptech, focused on developing disruptive technologies for digital resilience and new capabilities; and cleantech, which supports scalable solutions to address climate change. By partnering with scientists and entrepreneurs, IP Group works to develop defensible innovations with the potential to address significant global challenges, aiming to deliver both strong financial returns and positive societal impact.

Recent filings

Filing Released Lang Actions
Share buyback programme update
Share Issue/Capital Change Classification · 1% confidence The document is identified by the RNS Number (6561S) and the header 'RNS Number : 6561S', indicating it is a regulatory announcement from the London Stock Exchange's news service. The content explicitly discusses the launch and details of a share buyback extension ('Transaction in Own Shares') and confirms that the company will make further regulatory announcements regarding purchases. While the subject matter is share repurchase, the document itself is an announcement detailing the execution of this activity, which falls under the category of reporting transactions in own shares. The definition for 'Transaction in Own Shares' (POS) is 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. This is a direct report of that activity, not just a general regulatory filing (RNS) or a notice of dividend (DIV).
2025-01-09 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is explicitly titled "Transaction in Own Shares" and details the purchase of ordinary shares by the company (IP Group PLC) through a buyback programme, including the number of shares purchased, prices paid, and the resulting number of shares in issue. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The RNS Number and the closing statement referencing RNS confirm it is a regulatory announcement, but the specific content dictates the most precise classification, which is POS.
2025-01-08 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document is titled 'Transaction in Own Shares' and details the purchase of ordinary shares by IP Group plc on behalf of the company itself, pursuant to a share buyback programme. It provides specific dates, volumes, and prices of these transactions. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The RNS Number (3016S) and the closing boilerplate referencing RNS and the London Stock Exchange confirm it is a regulatory disclosure, but the specific content points directly to the POS code.
2025-01-06 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short regulatory announcement identified by the 'RNS Number' and the closing statement referencing RNS, the news service of the London Stock Exchange. The content explicitly states the total number of shares in issue and the total number of voting rights as of a specific month-end date (31 December 2024). This type of disclosure, mandated by Disclosure and Transparency Rule 5.6.1, relates to the company's capital structure and voting rights. While it touches upon capital structure, the primary focus is the monthly disclosure of voting rights, which is a specific regulatory filing requirement. It is not a comprehensive report (like 10-K or IR), nor is it a dividend announcement (DIV) or a director's dealing report (DIRS). Since it is a mandatory, specific regulatory update that doesn't fit perfectly into the other specialized categories (like AGM-R, ER, or CAP), the most appropriate classification is the general regulatory filing category, RNS, as it is explicitly branded as an RNS release.
2024-12-31 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject as "Transaction in Own Shares" and details the purchase of ordinary shares by the company (IP Group plc) through a broker as part of a "share buyback programme." This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance). The presence of the RNS Number and the closing statement referencing RNS, the London Stock Exchange, and the FCA confirms it is a regulatory disclosure related to share activity. The filing type code 'POS' is the most specific match.
2024-12-20 English
Form 8.3 - Intelligent Ultrasound Group plc
Regulatory Filings Classification · 1% confidence The document explicitly states it is a 'FORM 8.3' titled 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' under 'Rule 8.3 of the Takeover Code'. This type of disclosure relates to insider dealings or significant ownership changes during a takeover scenario. While it involves director/insider activity, the specific context of the Takeover Code (Rule 8.3) and the disclosure of interests/dealings related to an offer (Intelligent Ultrasound Group plc) strongly aligns with regulatory filings concerning insider transactions, which is often captured under Director's Dealing (DIRS) or general Regulatory Filings (RNS). Since the definitions provided do not have a specific code for 'Takeover Code Rule 8.3 Disclosure', and it details personal share transactions by an entity (IP Group plc) related to an offer, 'DIRS' (Director's Dealing) is the closest fit for reporting personal share transactions by executives/insiders, even though this is a specific regulatory form (Form 8.3). However, given the structure and the fact that it is a mandatory regulatory disclosure distributed via RNS, 'RNS' (Regulatory Filings) is a strong candidate as a fallback. Comparing DIRS and RNS: DIRS is for personal share transactions by directors/executives. This is a disclosure by a major shareholder/entity regarding an offer, which is a specific type of insider/related party transaction reporting. Since the document is a formal, structured regulatory filing distributed via RNS, and it is not a standard earnings report, annual report, or proxy statement, RNS is the most appropriate general category for specific, non-standard regulatory disclosures not covered elsewhere. The presence of 'RNS Number' and the footer confirming distribution by RNS supports this. I will classify it as RNS as it is a specific regulatory filing that doesn't fit the other specialized categories perfectly, although it shares characteristics with DIRS.
2024-12-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.